Financial Architects (New Jersey)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-170
Closed -$7K 1584
2018
Q4
$7K Hold
170
﹤0.01% 1089
2018
Q3
$9K Hold
170
﹤0.01% 1148
2018
Q2
$14K Hold
170
﹤0.01% 917
2018
Q1
$11K Hold
170
﹤0.01% 1059
2017
Q4
$9K Hold
170
﹤0.01% 1186
2017
Q3
$15K Hold
170
﹤0.01% 1036
2017
Q2
$10K Hold
170
﹤0.01% 1156
2017
Q1
$9K Hold
170
﹤0.01% 1172
2016
Q4
$8K Hold
170
﹤0.01% 1067
2016
Q3
$10K Hold
170
﹤0.01% 1013
2016
Q2
$9K Hold
170
﹤0.01% 1010
2016
Q1
$5K Buy
+170
New +$5.36K ﹤0.01% 919
2015
Q3
Sell
-170
Closed -$10K 1055
2015
Q2
$10K Sell
170
-2,000
-92% -$132K ﹤0.01% 807
2015
Q1
$168K Buy
+2,170
New +$125K 0.07% 217

Other funds holding ONCE

Financial Architects (New Jersey)'s ONCE Position: Q1 2019 in Review

Financial Architects (New Jersey) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 170 shares — an estimated $7K sold.

Financial Architects (New Jersey) first reported a position in ONCE in Q1 2015 and held it in 14 quarters. The position peaked at $168K in Q1 2015. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • Financial Architects (New Jersey) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 170 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $7K.
  • Financial Architects (New Jersey) first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 14 quarters.
  • Financial Architects (New Jersey)'s Spark Therapeutics, Inc. Common Stock position peaked at $168K in Q1 2015.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2019, filed 3 May 2019.